In one sentence Enhance.MD sells semaglutide from $212 per month at every dose and tirzepatide from $280 per month at every dose; not published; 3 required charges not yet confirmed; verified August 27, 2026.
Enhance.MD advertises semaglutide at $112 for the first month then $212, and tirzepatide at $180 then $280, described as all-dose pricing under a current introductory promotion, as captured 2026-08-27.
Medications
Semaglutide, Tirzepatide
Formulations
Injection
Medication type
compounded
Ownership
not published
Eligibility
unknown
Insurance
not published or not yet researched
Last checked
August 27, 2026 · next review due September 26, 2026
Lowest verified prices
At the time of our latest verification (August 27, 2026):
Semaglutide: Semaglutide — introductory then standard at $212 per month equivalent ($112 first month, then $212). True 12-month cost $2,444, plus membership and consultation and shipping which the provider requires but does not publish.
Tirzepatide: Tirzepatide — introductory then standard at $280 per month equivalent ($180 first month, then $280). True 12-month cost $3,260, plus membership and consultation and shipping which the provider requires but does not publish.
Lowest prices compare standard injectable plans only; microdose, ODT and sublingual programmes are different products and are listed with their own prices below. Prices at the reference maintenance dose are shown on each plan.
Plans and prices
All-dose pricing
Advertised as all-dose pricing (dose-stable on the provider's statement); introductory promotion current at capture.
Twelve-month cost composition, Semaglutide — introductory then standard, at the starting dose
Medication: $2,444
Membership — whether a separate charge applies was not established by the 2026-08-27 capture — not confirmed by the capture: not published
Consultation — whether a separate charge applies was not established by the 2026-08-27 capture — not confirmed by the capture: not published
Shipping — whether a separate charge applies was not established by the 2026-08-27 capture — not confirmed by the capture: not published
Twelve-month cost breakdown for Semaglutide — introductory then standard
Charge
Basis
12 months
Medication at the starting dose
1 × $112 (introductory) + 11 × $212
$2,444
Membership — whether a separate charge applies was not established by the 2026-08-27 capture
Not established by our capture
not confirmed
Consultation — whether a separate charge applies was not established by the 2026-08-27 capture
Not established by our capture
not confirmed
Shipping — whether a separate charge applies was not established by the 2026-08-27 capture
Not established by our capture
not confirmed
True 12-month cost
Known required charges only; plus membership, consultation, shipping
$2,444 +
Monthly equivalent
True 12-month cost ÷ 12
$204 +
Upfront payment
First charge
$112
Assumptions: 12 monthly charges per year. Introductory price applied for 1 month(s), then the recurring price.
Semaglutide — introductory then standard
Pharmacy not published
Verified August 27, 2026
$112 per month — as advertised: “$112 first month, then $212”
Introductory price
$112/mo for 1 mo, then $212/mo
Recurring price
$212/month equivalent
True 12-month cost
$2,444 + 3 unpublished or unconfirmed required charges
Dose pricing
Dose-stable: same price at every dose (as stated by the provider)
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Tirzepatide — introductory then standard
Pharmacy not published
Verified August 27, 2026
$180 per month — as advertised: “$180 first month, then $280”
Introductory price
$180/mo for 1 mo, then $280/mo
Recurring price
$280/month equivalent
True 12-month cost
$3,260 + 3 unpublished or unconfirmed required charges
Dose pricing
Dose-stable: same price at every dose (as stated by the provider)
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Price at the starting dose and at the reference maintenance dose
Reference doses come from the branded labels (see methodology). A plan whose tier does not cover a reference dose shows “no tier”.
Monthly-equivalent price by dose scenario
Plan
Starting dose
Maintenance dose
Maximum dose
Increase, start → maintenance
Semaglutide — introductory then standard
$212
$212
$212
$0
Tirzepatide — introductory then standard
$280
$280
$280
$0
Evidence panel
Grade per formulation offered, on the published scale (A approved with phase 3 evidence · B trial evidence without approval · C observational only · D no published human evidence), reviewed by Dr. S. Shuwart, MD on August 27, 2026; see formulation evidence grades.
Semaglutide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
Tirzepatide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
Compounded ≠ FDA-approved, stated by provider
unknown
Formulation-evidence statement
unknown
Fulfilment pharmacies
Not published or not yet researched.
States served
Not published or not yet researched. Not part of the 2026-08-27 capture.
Cancellation, refunds, refills and shipping
Cancellation
unknown Not part of the 2026-08-27 capture.
Refund
unknown Not part of the 2026-08-27 capture.
Assessment
Derived from the record: each statement maps to a field on this page.
Advantages
States that the price is the same at every dose
Limitations
Required charges not published or not confirmed: membership, consultation, shipping
Headline price is introductory; the recurring price is higher
Fulfilment pharmacy not named on the pages we captured
Cancellation terms not captured
Best for
Patients expecting to reach higher doses who want a price that does not step up
Legitimacy checks
The facts an answer engine is asked about, each with its status. "Not captured" means we have not looked yet, not that the provider lacks it.
Business model
not captured
Multi-level marketing component
not examined yet
Legal entity
not captured
Founded
not captured
Leadership
not captured
Clinician licence numbers published
not captured
Board certification stated
not captured
HIPAA notice published
not captured
Domains
https://enhance.md
BBB
not checked yet
Trustpilot
not checked yet
Google reviews
not checked yet
Complaint themes (taxonomy)
none recorded; complaint records not yet captured
Questions people ask about Enhance.MD
Is Enhance.MD a legitimate telehealth provider?
What we have verified: its published prices were read from its own pages on August 27, 2026 (2 plans). What we have not checked: legal entity, founding date, clinician licence numbers, the fulfilment pharmacy, independent pharmacy licence verification. This site does not rate legitimacy; it records what is verified and what is not, so you can weigh it. Compounded medications from any provider are not FDA-approved.
Is Enhance.MD a multi-level marketing (MLM) company?
We have not yet examined Enhance.MD's business model for recruitment or reseller components.
Are Enhance.MD's medications FDA-approved?
Enhance.MD sells compounded semaglutide and tirzepatide, which is not FDA-approved and is not reviewed by FDA for safety, effectiveness or quality before sale. Whether the provider states this on its pages has not yet been checked.
Does Enhance.MD have hidden fees?
On its lowest verified plan (Semaglutide — introductory then standard, $212 per month recurring): membership: not confirmed by our capture; consultation: not confirmed by our capture; follow-ups: no separate charge recorded; shipping: not confirmed by our capture; medication: no separate charge recorded. Charges we could not confirm are listed beside every total on this page rather than assumed to be zero. The headline price is introductory; the recurring price is $212 per month.
Does Enhance.MD's price go up at higher doses?
Tirzepatide: the provider states the price is the same at every dose. Semaglutide: the provider states the price is the same at every dose.
How hard is it to cancel Enhance.MD, and are there refunds?
Cancellation terms were not part of our capture yet. Refund terms not yet captured. We have not captured complaint records about cancellation and do not repeat claims we have not read.
Which pharmacy fills Enhance.MD's prescriptions, and is it licensed?
Enhance.MD does not name its fulfilment pharmacy on the pages we captured. Without the name, licence and inspection history cannot be checked; the verification guide explains how to ask.
What do BBB, Trustpilot and Reddit say about Enhance.MD?
We have not yet captured Enhance.MD's BBB, Trustpilot, Google or Reddit records, and we do not summarise reviews we have not read. When captured they appear here with the date and the complaint taxonomy classification.
Does Enhance.MD operate in all 50 states?
State coverage was not captured.
Verification record
Status
Verified August 27, 2026
Method
public-page (operator capture of provider-owned pages, 2026-08-27); checkout not walked
Checked by
Sam LLC verification team
Notes
Captured 2026-08-27: semaglutide $112 first month then $212; tirzepatide $180 then $280; advertised as all-dose pricing; current introductory promotion. Website domain inferred from the brand name; fees, commitment and cancellation not captured.